Vitiligo

"Vitiligo" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.

Descriptor ID	D014820
MeSH Number(s)	C17.800.621.440.895
Concept/Terms	Vitiligo Vitiligo

Below are MeSH descriptors whose meaning is more general than "Vitiligo".

Diseases [C]
Skin and Connective Tissue Diseases [C17]
Skin Diseases [C17.800]
Pigmentation Disorders [C17.800.621]
Hypopigmentation [C17.800.621.440]
Vitiligo [C17.800.621.440.895]

Below are MeSH descriptors whose meaning is related to "Vitiligo".

Below are MeSH descriptors whose meaning is more specific than "Vitiligo".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Vitiligo" by people in this website by year, and whether "Vitiligo" was a major or minor topic of these publications.

Bar chart showing 9 publications over 8 distinct years, with a maximum of 2 publications in 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2003	1	0	1
2007	0	1	1
2013	2	0	2
2014	1	0	1
2015	1	0	1
2017	1	0	1
2020	1	0	1
2021	1	0	1

Below are the most recent publications written about "Vitiligo" by people in Profiles.

Elston D. This Month in JAAD: June 2021. J Am Acad Dermatol. 2021 06; 84(6):1542.

View in: PubMed
Mukhatayev Z, Dellacecca ER, Cosgrove C, Shivde R, Jaishankar D, Pontarolo-Maag K, Eby JM, Henning SW, Ostapchuk YO, Cedercreutz K, Issanov A, Mehrotra S, Overbeck A, Junghans RP, Leventhal JR, Le Poole IC. Antigen Specificity Enhances Disease Control by Tregs in Vitiligo. Front Immunol. 2020; 11:581433.

View in: PubMed
Le Poole IC, Mehrotra S. Replenishing Regulatory T Cells to Halt Depigmentation in Vitiligo. J Investig Dermatol Symp Proc. 2017 10; 18(2):S38-S45.

View in: PubMed
Eby JM, Kang HK, Tully ST, Bindeman WE, Peiffer DS, Chatterjee S, Mehrotra S, Le Poole IC. CCL22 to Activate Treg Migration and Suppress Depigmentation in Vitiligo. J Invest Dermatol. 2015 Jun; 135(6):1574-1580.

View in: PubMed
Eby JM, Kang HK, Klarquist J, Chatterjee S, Mosenson JA, Nishimura MI, Garrett-Mayer E, Longley BJ, Engelhard VH, Mehrotra S, Le Poole IC. Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation. Pigment Cell Melanoma Res. 2014 Nov; 27(6):1075-85.

View in: PubMed
Chatterjee S, Eby JM, Al-Khami AA, Soloshchenko M, Kang HK, Kaur N, Naga OS, Murali A, Nishimura MI, Caroline Le Poole I, Mehrotra S. A quantitative increase in regulatory T cells controls development of vitiligo. J Invest Dermatol. 2014 May; 134(5):1285-1294.

View in: PubMed
Mosenson JA, Zloza A, Nieland JD, Garrett-Mayer E, Eby JM, Huelsmann EJ, Kumar P, Denman CJ, Lacek AT, Kohlhapp FJ, Alamiri A, Hughes T, Bines SD, Kaufman HL, Overbeck A, Mehrotra S, Hernandez C, Nishimura MI, Guevara-Patino JA, Le Poole IC. Mutant HSP70 reverses autoimmune depigmentation in vitiligo. Sci Transl Med. 2013 Feb 27; 5(174):174ra28.

View in: PubMed
Paulos CM, Wrzesinski C, Kaiser A, Hinrichs CS, Chieppa M, Cassard L, Palmer DC, Boni A, Muranski P, Yu Z, Gattinoni L, Antony PA, Rosenberg SA, Restifo NP. Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling. J Clin Invest. 2007 Aug; 117(8):2197-204.

View in: PubMed
Muwakkit S, Locatelli F, Abboud M, Razzouk B, Wilimas J. Report of a child with vitiligo and Evans syndrome. J Pediatr Hematol Oncol. 2003 Apr; 25(4):344-5.

View in: PubMed

People

Explore

Similar Concepts

Top Journals